兰州大学机构库
SH229 plus daclatasvir for treatment of chronic hepatitis C virus infection in China: a single-arm, open-label, phase 3 study
2021-07
Source PublicationJOURNAL OF HEPATOLOGY
ISSN0168-8278
Volume75
PagesS795-S795
PublisherELSEVIER
Indexed BySCOPUS ; SCIE
Language英语
WOS Research AreaGastroenterology & Hepatology
WOS SubjectGastroenterology & Hepatology
WOS IDWOS:000667753802172
Original Document TypeMeeting Abstract
Citation statistics
Document Type会议论文
Identifierhttp://ir.lzu.edu.cn/handle/262010/452611
Collection兰州大学
Affiliation1.First Hosp Jilin Univ, Changchun, Peoples R China;
2.Liuzhou Peoples Hosp, Liuzhou, Peoples R China;
3.Sichuan Prov Peoples Hosp, Chengdu, Peoples R China;
4.Sixth Peoples Hosp Shenyang, Shenyang, Peoples R China;
5.Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China;
6.Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China;
7.Xinjiang Uygur Autonomous Reg Hosp Tradit Chinese, Urumqi, Peoples R China;
8.Yanbian Univ, Affiliated Hosp, Yanbian, Peoples R China;
9.Cent South Univ, Xiangya Hosp, Changsha, Peoples R China;
10.Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China;
11.Army Med Univ, Southwest Hosp, Affiliated Hosp 1, Chongqing, Peoples R China;
12.Guangzhou Eighth Peoples Hosp, Guangzhou, Peoples R China;
13.PLA, Hosp Joint Logist Support Force 940, Lanzhou, Peoples R China;
14.Zhengzhou Peoples Hosp, Zhengzhou, Peoples R China;
15.Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China;
16.Second Hosp Nanjing, Nanjing, Peoples R China;
17.Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China;
18.Peking Univ, Peoples Hosp, Beijing, Peoples R China;
19.Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China;
20.Wuxi Fifth Peoples Hosp, Wuxi, Jiangsu, Peoples R China;
21.Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China;
22.Fourth Mil Med Univ, Chinese Peoples Liberat Army, Tangdu Hosp, Xian, Peoples R China;
23.Harbin Med Univ, Affiliated Hosp 4, Harbin, Peoples R China;
24.Qingdao Municipal Hosp, Qingdao, Peoples R China;
25.Jiangyin Peoples Hosp, Jiangyin, Peoples R China;
26.Tonghua Cent Hosp, Tonghua, Peoples R China;
27.Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China;
28.Shulan Hangzhou Hosp, Hangzhou, Peoples R China;
29.Third Peoples Hosp Zhenjiang, Zhenjiang, Jiangsu, Peoples R China;
30.Foshan First Peoples Hosp, Foshan, Peoples R China;
31.PLA, Hosp Joint Logist Support Force 900, Fuzhou, Peoples R China;
32.Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China;
33.Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China;
34.Zhengzhou Sixth Peoples Hosp, Zhengzhou, Peoples R China;
35.Nanjing Sanhome Pharmaceut Co Ltd, Nanjing, Peoples R China;
36.Xinjiang Med Univ, Hosp 1, Urumqi, Peoples R China
First Author AffilicationFirst Clinical School
Recommended Citation
GB/T 7714
Hua, Rui,Kong, Fei,Wen, Xiaofeng,et al. SH229 plus daclatasvir for treatment of chronic hepatitis C virus infection in China: a single-arm, open-label, phase 3 study[C],2021:S795-S795.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Hua, Rui]'s Articles
[Kong, Fei]'s Articles
[Wen, Xiaofeng]'s Articles
Baidu academic
Similar articles in Baidu academic
[Hua, Rui]'s Articles
[Kong, Fei]'s Articles
[Wen, Xiaofeng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Hua, Rui]'s Articles
[Kong, Fei]'s Articles
[Wen, Xiaofeng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.